The authors of a recent study used an Abeta ELISA Kit that is available at antibodies-online. The published study shows that some curcumin mixes have a potent anti-amyloidogenic effect via modulation of BACE1 and APP and hence may be promising for AD treatment and prevention.

There is evidence that a hallmark of Alzheimer's disease (AD) is the accumulation of beta-amyloid protein (Abeta). Abeta is generated from the beta-amyloid precursor protein (APP) through the proteolysis of beta-site APP cleaving enzyme 1 (BACE1) and gamma-secretase.

The study can be found here: